Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:tizanidine
|
| gptkbp:ATCCode |
gptkb:M03BX02
|
| gptkbp:contraindication |
severe liver impairment
concomitant use with CYP1A2 inhibitors |
| gptkbp:drugClass |
muscle relaxant
|
| gptkbp:firstApproval |
1980s
|
| gptkbp:form |
gptkb:tablet
capsule |
| gptkbp:halfLife |
2.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sirdalud
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
fatigue
drowsiness hypotension dry mouth |
| gptkbp:usedFor |
muscle spasms
muscle spasticity |
| gptkbp:bfsParent |
gptkb:tizanidine
|
| gptkbp:bfsLayer |
8
|